文献速递乳腺癌支持与姑息治疗

健康的社会基因组决定因素:理解社区不利环境通过分子通路影响癌症结局

Social Genomic Determinants of Health: Understanding the Molecular Pathways by Which Neighborhood Disadvantage Affects Cancer Outcomes.
PubMed 文献 · J Clin Oncol · 2024-08-23

社区不利环境与乳腺癌无复发生存期(RFS)缩短相关,且独立于个体层面(种族、民族、社会经济地位、保险、肿瘤特征)和卫生系统层面(接受指南一致治疗)的决定因素。本文提出一个转化流行病学框架,通过社会基因组学和社会表观基因组学视角,阐明社区不利环境如何经生理性基因调控通路影响癌症基因组活性及肿瘤微环境,进而改变疾病进展和治疗结局。

要点

  • 社区不利环境与乳腺癌RFS缩短独立相关,不受个体和卫生系统因素解释。
  • 提出社会基因组决定因素概念:情境因素经神经/内分泌调控基因表达和表观遗传过程影响癌症基因组与微环境。
  • 构建多水平健康决定因素模型,纳入政治、卫生系统、社会、心理社会、个体和社会基因组因素以理解肿瘤结局差异。

核心结论

  • 社区不利环境与乳腺癌RFS缩短独立相关,提示其背后存在未被解释的机制,如更具侵袭性的肿瘤生物学。
  • 提出新的多水平健康决定因素模型,通过转化流行病学方法评估政治、卫生系统、社会、心理社会、个体和社会基因组决定因素之间的相互作用,以理解肿瘤结局的社会差异。
  • 提供了一条具体的生物学通路,说明社会过程和社会流行病学如何影响癌症基础生物学并最终影响临床结局和生存。

研究设计与样本

  • 本文为转化流行病学框架的构建,采用转化差异方法,通过社会基因组学和社会表观基因组学视角研究癌症结局差异。
  • 框架基于对社区不利环境与乳腺癌RFS之间独立关联的观察,该关联独立于个体层面(种族、民族、社会经济地位、保险、肿瘤特征)和卫生系统层面(接受指南一致治疗)的决定因素。

主要发现

  • 社区不利环境与乳腺癌RFS缩短独立相关,且独立于个体层面(种族、民族、社会经济地位、保险、肿瘤特征)和卫生系统层面(接受指南一致治疗)的决定因素。
  • 这种持续存在的RFS差异提示,居住在不利社区的女性相比有利社区的女性可能存在更具侵袭性的肿瘤生物学等未被解释的机制。
  • 社会基因组决定因素被定义为生理性基因调控通路(即基因表达的神经/内分泌控制和表观遗传过程),情境因素特别是社区环境可通过这些通路影响癌症基因组活性及周围肿瘤微环境,从而改变疾病进展和治疗结局。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Neighborhoods represent complex environments with unique social, cultural, physical, and economic attributes that have major impacts on disparities in health, disease, and survival. Neighborhood disadvantage is associated with shorter breast cancer recurrence-free survival (RFS) independent of individual-level (race, ethnicity, socioeconomic status, insurance, tumor characteristics) and health system-level determinants of health (receipt of guideline-concordant treatment). This persistent disparity in RFS suggests unaccounted mechanisms such as more aggressive tumor biology among women living in disadvantaged neighborhoods compared with advantaged neighborhoods. The objective of this article was to provide a clear framework and biological mechanistic explanation for how neighborhood disadvantage affects cancer survival. METHODS: Development of a translational epidemiological framework that takes a translational disparities approach to study cancer outcome disparities through the lens of social genomics and social epigenomics. RESULTS: The social genomic determinants of health, defined as the physiological gene regulatory pathways (ie, neural/endocrine control of gene expression and epigenetic processes) through which contextual factors, particularly one's neighborhood, can affect activity of the cancer genome and the surrounding tumor microenvironment to alter disease progression and treatment outcomes. CONCLUSION: We propose a novel, multilevel determinants of health model that takes a translational epidemiological approach to evaluate the interplay between political, health system, social, psychosocial, individual, and social genomic determinants of health to understand social disparities in oncologic outcomes. In doing so, we provide a concrete biological pathway through which the effects of social processes and social epidemiology come to affect the basic biology of cancer and ultimately clinical outcomes and survival.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Goel N, Hernandez A, Cole SW, et al. Social Genomic Determinants of Health: Understanding the Molecular Pathways by Which Neighborhood Disadvantage Affects Cancer Outcomes. J Clin Oncol. 2024. PMID: 39178356. doi:10.1200/JCO.23.02780

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。